Status:
COMPLETED
Serum Selenium and Zinc Levels in Non-alcoholic Fatty Liver Disease Patients
Lead Sponsor:
Sohag University
Conditions:
NAFLD
Eligibility:
All Genders
20-80 years
Brief Summary
Non-alcoholic fatty liver disease (NAFLD) includes a wide range of disorders that consist of simple fatty infiltration, steatohepatitis (NASH), and end-stage liver disease (cirrhosis). NAFLD is the mo...
Detailed Description
We aim firstly to assess the serum selenium and zinc level in NAFLD patients, secondly to detect the association between hepatic fibrosis, steatosis, and serum selenium level in NAFLD patients, thirdl...
Eligibility Criteria
Inclusion
- patients diagnosed to have NAFLD by ultrasonography presented to the outpatient clinic of Tropical medicine and gastroenterology department, Sohag University Hospitals during the period from March 2021 to August 2021.
Exclusion
- Any patient with a chronic liver disease rather than NAFLD
Key Trial Info
Start Date :
March 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 25 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04834063
Start Date
March 15 2021
End Date
September 25 2021
Last Update
November 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mona Mohammed Abdelrahman
Sohag, Egypt